你即將離開本站

並前往https://clinicaltrials.gov/ct2/show/NCT03318939

Phase 2 Study of Poziotinib in Patients With NSCLC Having ...

Cohort 5: Documented EGFR or HER2 exon 20 insertion mutations; Cohort 6: Documented acquired EGFR mutation (tested after osimertinib progression) ...

確定！ 回上一頁

查詢 「Insertion mutation」的人也找了：

  1. insertion mutation中文
    2.
  2. Inversion mutation
    3.
  3. Structural mutation
    4.
  4. Gene mutation
    5.
  5. DNA mutation
    6.
  6. Nonsense mutation
    7.
  7. Insertion mutation
    8.
  8. Silent mutation
    9.